Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis
Loading...
Identifiers
Publication date
Authors
Severo Sánchez, Andrea
Espriella, Rafael de la
Valero Masa, María Jesús
García Vega, David
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
Current evidence supports the role of circulating carbohydrate antigen 125 (CA125) in risk assessment, disease monitoring and therapeutic guidance in heart failure (HF). However, there is limited data on its diagnostic applicability. This study aimed to assess the diagnostic performance of CA125 in identifying HF with preserved ejection fraction (HFpEF) in an outpatient population.
Description
Keywords
Bibliographic reference
De Juan Bagudá, J., Severo Sánchez, A., De La Espriella, R., Valero-Masa, M. J., García-Vega, D., De Antonio Ferrer, M., Segura De La Cal, T., Mollar, A., García-Cosío Carmena, M. D., Martínez-Dolz, L., De La Cruz, J., González-Juanatey, J. R., Martínez-Sellés, M., Núñez, J., & Delgado Jiménez, J. F. (2025). Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis. Heart, heartjnl-2025-326053. https://doi.org/10.1136/heartjnl-2025-326053